MetaMorphix Seeks To Convert Case To Ch. 7

Law360, New York (March 21, 2011, 7:45 PM EDT) -- Following the sale of its assets to noteholders for a $6 million credit bid, MetaMorphix Inc. on Friday asked a Delaware bankruptcy court to convert its Chapter 11 case into a Chapter 7 liquidation proceeding.

The biotechnology company and its MMI Genomics Inc. unit said following Friday’s closing of the sale to Branhaven LLC, which is the collateral agent for noteholders owed $34 million, that the debtors had no assets left to facilitate a Chapter 11 reorganization in the U.S. Bankruptcy Court for the District of...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.